Search

everythinglearnresearchcommunity

for

Search:↓

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

The mouse models are effective for testing new hair loss treatments.

Some supplements and hormones can increase hair loss by raising DHT levels.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Gene mutations can cause problems in male genital development.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Bleaching hair damages protein structure, especially keratin, leading to weakened hair.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.